{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:13:45Z","timestamp":1793261625360,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejvs.2024.07.041","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T04:19:13Z","timestamp":1723090753000},"page":"737-745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Editor's Choice \u2013 Major Adverse Limb Events in Patients Undergoing Revascularisation for Lower Limb Peripheral Arterial Disease: A Nationwide Observational Study"],"prefix":"10.1016","volume":"68","author":[{"given":"Vishal","family":"Amlani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Ludwigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidin","family":"Rawshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5431-9365","authenticated-orcid":false,"given":"Marcus","family":"Thuresson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Falkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Smidfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2670-2268","authenticated-orcid":false,"given":"Joakim","family":"Nordanstig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2024.07.041_bib1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.ejvs.2024.07.041_bib2","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.07.041_bib3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jvs.2016.03.429","article-title":"Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization","volume":"64","author":"Sigvant","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.07.041_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/2047487313519344","article-title":"Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study","volume":"22","author":"Subherwal","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ejvs.2024.07.041_bib6","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.amjcard.2019.03.022","article-title":"Incidence and cost of major adverse cardiovascular events and major adverse limb events in patients with chronic coronary artery disease or peripheral artery disease","volume":"123","author":"Berger","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2024.07.041_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"290","year":"2019","journal-title":"Atherosclerosis"},{"issue":"Suppl. 102","key":"10.1016\/j.ejvs.2024.07.041_bib8","first-page":"1","article-title":"ESVM guideline on peripheral arterial disease","volume":"48","author":"Frank","year":"2019","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2024.07.041_bib9","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1161\/CIRCULATIONAHA.117.024469","article-title":"A\u00a0structured review of antithrombotic therapy in peripheral artery disease with a focus on revascularization: a TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) initiative","volume":"135","author":"Hess","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.07.041_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jvs.2022.04.012","article-title":"Society for Vascular Surgery appropriate use criteria for management of intermittent claudication","volume":"76","author":"Woo","year":"2022","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib12","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2024.07.041_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.10765","article-title":"Risk of major amputation in patients with intermittent claudication undergoing early revascularization","volume":"105","author":"Golledge","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacc.2019.11.050","article-title":"Long-term outcomes and associations with major adverse limb events after peripheral artery revascularization","volume":"75","author":"Hess","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2024.07.041_bib15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.121.055146","article-title":"Reduction in acute limb ischemia with rivaroxaban versus placebo in peripheral artery disease after lower extremity revascularization: insights from VOYAGER PAD","volume":"144","author":"Hess","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.07.041_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ejvs.2019.11.023","article-title":"Low risk of procedure related major amputation following revascularisation for intermittent claudication: a population based study","volume":"59","author":"Djerf","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejvs.2017.07.005","article-title":"Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: a population based study","volume":"54","author":"Baubeta Fridh","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib18","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2024.07.041_bib19","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2024.07.041_bib20","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(23)00462-2","volume":"401","author":"Bradbury","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2024.07.041_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12325-019-01132-z","article-title":"Real-world predictors of major adverse cardiovascular events and major adverse limb events among patients with chronic coronary artery disease and\/or peripheral arterial disease","volume":"37","author":"Berger","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.ejvs.2024.07.041_bib22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ejvs.2015.07.021","article-title":"International Vascunet validation of the Swedvasc registry","volume":"50","author":"Venermo","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejvs.2008.08.017","article-title":"External validation of the Swedvasc registry: a first-time individual cross-matching with the unique personal identity number","volume":"36","author":"Troeng","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A\u00a0new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Automat Contr"},{"key":"10.1016\/j.ejvs.2024.07.041_bib26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ejvs.2018.06.003","article-title":"Editor\u2019s Choice \u2013 Impact of comorbidity, medication, and gender on amputation rate following revascularisation for chronic limb threatening ischaemia","volume":"56","author":"Baubeta Fridh","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1358863X18824654","article-title":"Unique aspects of peripheral artery disease in patients with chronic kidney disease","volume":"24","author":"Arinze","year":"2019","journal-title":"Vasc Med"},{"key":"10.1016\/j.ejvs.2024.07.041_bib28","first-page":"21","article-title":"Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial","volume":"6","author":"Kaplovitch","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejvs.2024.07.041_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.23736\/S0392-9590.21.04816-1","article-title":"Prevalence of VOYAGER PAD trial exclusion criteria in unselected patients undergoing lower limb revascularization","volume":"41","author":"Moll","year":"2022","journal-title":"Int Angiol"},{"key":"10.1016\/j.ejvs.2024.07.041_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejvs.2021.10.026","article-title":"Revascularisation for symptomatic peripheral artery disease: external applicability of the VOYAGER PAD trial","volume":"63","author":"S\u00f8gaard","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib31","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jvs.2009.09.044","article-title":"Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia","volume":"50","author":"Conte","year":"2009","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.07.041_bib32","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jcin.2021.08.079","article-title":"Objective outcome measures for trials in patients with chronic limb-threatening ischemia across 2 decades","volume":"14","author":"Lakhter","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2024.07.041_bib33","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2014.12.036","article-title":"Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)","volume":"65","author":"Patel","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2024.07.041_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.119.039773","article-title":"Acute limb ischemia in peripheral artery disease","volume":"140","author":"Hess","year":"2019","journal-title":"Circulation"},{"issue":"1S","key":"10.1016\/j.ejvs.2024.07.041_bib35","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588424006531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588424006531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T14:05:05Z","timestamp":1734012305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588424006531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1078588424006531"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.07.041","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editor's Choice \u2013 Major Adverse Limb Events in Patients Undergoing Revascularisation for Lower Limb Peripheral Arterial Disease: A Nationwide Observational Study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}